In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ortho-Clinical Diagnostics Inc.

www.orthoclinical.com

Latest From Ortho-Clinical Diagnostics Inc.

Antibody Testing During And After The Pandemic: Not All Tests Are Created Equal

While the main role of SARS-CoV-2 antibody testing is currently limited to determining exposure to the virus in populations, the scientific community is working hard to define the neutralizing properties of the antibodies detected, and the duration of the immune response. As a result, antibody testing could be here to stay for the long term for monitoring populations, testing vaccines and selecting patients for trials of a variety of new therapies to treat numerous conditions.

Research & Development Clinical Trials

Controversial Italian COVID-19 IVDs Tender Must Not Be A Blueprint For The Future, Says Industry

Italy must ensure that ongoing efforts to tackle the coronavirus crisis do not rely on single suppliers, the country's medtech industry body said after DiaSorin looked likely to be the sole winner of a major COVID-19 diagnostics tender.

Italy Coronavirus COVID-19

Abbott Rolls Out COVID-19 Antibody Test

Abbott has launched its first COVID-19 antibody test to help determine if a person has been previously infected with the virus. The diagnostics giant said it intends to ship a total of 4 million tests in April.

Coronavirus COVID-19 Diagnostics

COVID-19: Nanomix Wins BARDA Funding For Mobile Point-Of-Care Assay

The US government’s Biomedical Advanced Research and Development Authority has awarded Nanomix up to $570,000 to develop a SARS-CoV-2 test for its portable, rapid Nanomix eLab analyzer.

Coronavirus COVID-19 Infectious Diseases
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Therapeutic Drug Monitoring
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ortho-Clinical Diagnostics Inc.
  • Senior Management
  • Martin D Madaus, PhD, Chmn. & CEO
    Jeffrey D Capello, CFO
    Alex Socarras, EVP, Commercial
    Robert Yates, COO
  • Contact Info
  • Ortho-Clinical Diagnostics Inc.
    Phone: (800) 828-6316
    100 Indigo Creek Dr.
    Rochester, NJ 14626
    USA
UsernamePublicRestriction

Register